In addition, 1 in 8 people in the world are living with obesity, stated the World Health Organization (WHO)
This streamlines the telehealth prescribing process and removes layers of bureaucratic friction that exist in more restrictive states
Injectable Semaglutide : Subcutaneous injections of liraglutide 3mg (once daily) and semaglutide 2.4mg (once weekly) have been approved for the management of obesity
While GLP-1 medications were originally developed to help treat type 2 diabetes, they are now being used as an effective weight management solution for individuals with or without diabetes
Sleep debt, insulin resistance, under-recovery, thyroid dysfunction, and chronic stress signaling can all influence how well your system mobilizes and uses fat
The update comes soon after the World Health Organization updated its guidelines for obesity treatment, citing the combination of GLP-1 drugs, a healthy diet and exercise being integral for success among patients